Barceloneta, P.R.
U.S. pharmaceutical company Abbott opened the new 330,000-sf Abbott Biotechnology Limited plant in Barceloneta, Puerto Rico, in spring of 2007. Housing over 80 cell growth vessels and 12,000 liter bioreactor tanks, the $450 million plant will accommodate production of monoclonal antibodies and large scale product manufacturing. The project delivery timeline for the plant included two years of construction and two years for completion of validation and regulatory approvals.
